Search

everythinglearnresearchcommunity

for

Search:↓

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Targeting specific T cells may help treat alopecia areata.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Autoimmune reactions may cause both alopecia areata and HAM.

The assay effectively identifies compounds that affect immune cell activation.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

IL-18 signaling helps mature Tregs move into the thymus.

B cells can both help and hinder the body's defense against melanoma.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

CD34 marks potential stem cells in dog hair follicles.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Hair follicles help skin immune recovery after UVB exposure.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Alopecia areata involves specific immune cells, offering potential treatment targets.

A new mouse model effectively mimics vitiligo for research and drug testing.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

The Fas/FasL pathway may play a role in alopecia areata.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.